BioXcel Therapeutics, Inc. (BTAI)
NASDAQ·Healthcare·Biotechnology
$0.80
-4.89%
Mkt Cap $29.51M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$12.00
Range $1.00 – $25.00
Implied Upside
+1395.3%
Consensus $12.00 vs current $0.80
NASDAQ·Healthcare·Biotechnology
$0.80
-4.89%
Mkt Cap $29.51M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$12.00
Range $1.00 – $25.00
+1395.3%
Consensus $12.00 vs current $0.80